LABX stock forecast, quote, news & analysis

Key Takeaways

• LABX seeks to deliver two times (200%) the daily return of ALAB common shares, making it one of the most volatile single-stock leveraged ETFs (exchange-traded funds) available to U.S. investors.
• The fund gained roughly 19% over the last 30 days, rebounding from a mid-September trough near $8.86 to $10.52 by mid-October.
• The advance followed a sharp AI- and semiconductor-led selloff in mid-September, when warnings about the pace of artificial-intelligence development briefly pressured connectivity and chip names.
• Over the trailing quarter, LABX remains deeply lower at approximately -42%, reflecting a severe July drawdown and the compounding effects of daily leverage.
• Because LABX resets its exposure daily, multi-day returns can diverge materially from two times the underlying stock's move.

Tradr 2X Long ALAB Daily ETF (LABX) Overview and Portfolio Exposure

LABX is an actively managed, non-diversified leveraged ETF that seeks daily investment results, before fees and expenses, corresponding to 200% of the daily performance of the common shares of ALAB. Astera Labs designs semiconductor-based connectivity solutions for cloud and AI infrastructure, including PCIe and CXL retimers, Ethernet cable modules, memory controllers, and fabric switches.

The fund maintains its leveraged exposure primarily through total return swap agreements, with the remainder of assets held in U.S. Treasury securities and cash instruments used as collateral. This structure concentrates the portfolio almost entirely on a single issuer, and gross exposure can exceed 100% of net assets as leverage is applied. LABX carries a net expense ratio of 1.30% and was launched in August 2025, with assets under management (AUM) in the tens of millions of dollars. The strategy is classified within the technology and semiconductors space, but in practice its returns are driven almost entirely by Astera Labs' share-price action rather than broad sector diversification.

Tradr 2X Long ALAB Daily ETF (LABX) Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, LABX advanced approximately 19%, rising from a close near $8.86 in mid-September to $10.52 by mid-October. The move was anything but linear: the fund swung from a low near $7.85 to an intraday peak above $18 before giving back a large portion of the gain in early October.

The longer-term picture is far weaker. Over the trailing quarter, LABX declined roughly 42%, falling from about $18 in mid-July to $10.52. This divergence between the 30-day rebound and the deeper quarterly loss underscores how quickly leveraged single-stock ETFs can reverse, with the daily reset mechanism amplifying both directions of movement and creating compounding drag during choppy markets.

What Drove LABX Price in the Last 30 Days

The 30-day gain is largely a rebound from a sharp, sentiment-driven selloff. In mid-September, warnings from leaders of major AI laboratories about the pace of frontier-model development triggered a broad retreat in semiconductor and AI-infrastructure equities. The PHLX Semiconductor Index fell roughly 6% in a single session, and Astera Labs dropped more than 10% intraday, dragging LABX to its recent lows.

From that trough, the fund recovered as investors refocused on Astera Labs' underlying fundamentals: record second-quarter revenue that grew more than 100% year over year, strong guidance for the third quarter, and momentum in its Scorpio fabric-switch ramp and next-generation PCIe connectivity products.

The rally was partially reversed in October. A downgrade citing valuation, reports of insider share sales, and a renewed sector-wide pullback in semiconductor stocks—driven in part by rising Treasury yields, hotter-than-expected producer-price inflation, and concerns about memory-chip oversupply—pressured Astera Labs and pulled LABX back from its early-October peak.

What Drove LABX Performance Over the Last Quarter

The quarterly decline traces mainly to July, when AI-infrastructure names sold off sharply amid renewed questions about AI capital-spending durability and high valuations. Astera Labs, which trades at a premium multiple, was among the more volatile names in the group, and LABX's 200% daily leverage magnified those losses well beyond the underlying stock's decline.

The compounding structure of the fund also contributed. When a leveraged ETF resets daily, a sequence of alternating gains and losses can erode value over time even if the underlying security merely oscillates. That dynamic, combined with sustained two-way volatility in semiconductor equities, helps explain why LABX's quarterly performance was substantially worse than two times Astera Labs' own three-month move.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. It is designed to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening, allowing users to narrow the investable universe by customized criteria. For investors monitoring leveraged and thematic funds such as LABX, the tool offers a way to compare momentum, risk, and sector conditions across a broad set of instruments. Explore the AI Screener to refine your research workflow.

LABX ETF Outlook: What Investors Should Watch Next

Several factors are likely to shape LABX in the months ahead. Astera Labs' third-quarter earnings report is a pivotal near-term event, with the company's guidance and commentary on Scorpio switch volumes, PCIe product adoption, and optical-interconnect roadmaps likely to drive short-term volatility. Broader AI capital-expenditure trends among major hyperscalers also remain central, given Astera Labs' reliance on large cloud customers.

On the macro side, interest-rate expectations and inflation data matter directly: higher borrowing costs can weigh on richly valued semiconductor and AI-infrastructure equities. Sector sentiment, valuation multiples, insider selling activity, and memory-chip supply dynamics will also influence the underlying stock. Finally, investors should account for the structural risks inherent to LABX itself—daily leverage, single-issuer concentration, and compounding—which make it unsuitable for buy-and-hold objectives over longer horizons.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations